by scalewp | Apr 1, 2014 | Uncategorized
Prasco to market the Authorized Generic of EVISTA® in the United States CINCINNATI, OH April 1, 2014 – Prasco Laboratories, announced today it has signed a marketing and distribution agreement with Eli Lilly and Company (NYSE: LLY) to market the Authorized Generic...
by scalewp | Mar 11, 2014 | Uncategorized
Prasco has Begun Distribution of Doxercalciferol Capsules CINCINNATI, OH March 11, 2014 — Prasco Laboratories announced today it has begun shipping Doxercalciferol 0.5, 1.0 & 2.5 mcg capsules, each in 50-count bottles under the Prasco label. Prasco entered into a...
by scalewp | Oct 17, 2013 | Uncategorized
CINCINNATI, October 17, 2013 — Prasco Laboratories announced today it has signed an exclusive distribution and supply agreement with Shire for the Authorized Generic of FOSRENOL® (lanthanum carbonate) Chewable Tablets. As part of the agreement, Prasco will market...
by scalewp | May 7, 2013 | Uncategorized
CINCINNATI, May 1, 2013 / PRNewswire/ — Prasco Laboratories announced today it has signed an exclusive distribution and supply agreement with WellSpring Pharmaceutical Corp. for Phenoxybenzamine Hydrochloride Capsules, USP. As part of the agreement, Prasco, LLC is...
by scalewp | Jan 7, 2013 | Uncategorized
– Ferring Pharmaceuticals Joins Prasco’s Growing Family of Brand Partners CINCINNATI, OH; 1/07/13 — Prasco Laboratories announced today it began shipping the Authorized Generic of Ferring’s LYSTEDA® (tranexamic acid) Tablets in 650 mg strength in the U.S. under...
Recent Comments